Mereo BioPharma Group plc Confidential and Anonymous Financial Concern Hotline

The SEC, in its final ruling regarding standards relating to Audit Committees, requires that Mereo BioPharma Group plc provide a facility for the receipt, retention and treatment of complaints received regarding accounting, internal accounting controls or auditing matters.

Please feel free to contribute any comments through the interface linked to below regarding such accounting matters. Your message is encrypted and will be delivered directly to the Audit Committee.

https://www.whistleblowerservices.com/mreo/